{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:43:09Z","timestamp":1782218589832,"version":"3.54.5"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>New approaches are needed to provide care for individuals with problematic opioid use (POU). Rapid access addiction medicine (RAAM) clinics offer a flexible, low-barrier, rapid access care model for this population.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess the associations of RAAM clinics with emergency department (ED) visits, hospitalizations, and mortality for people with POU.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>A retrospective cohort study involving a matched control group was performed using health administrative data from Ontario, Canada. Anonymized data from 4 Ontario RAAM clinics (cities of Ottawa, Toronto, Oshawa, and Sudbury) were linked with health administrative data. Analyses were performed on a cohort of individuals who received care at participating RAAM clinics and geographically matched controls who did not receive care at a RAAM clinic. All visits occurred between October 2, 2017, and October 30, 2019, and data analyses were completed in spring 2023. A propensity score\u2013matching approach was used to balance confounding factors between groups, with adjustment for covariates that remained imbalanced after matching.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Individuals who initiated care through the RAAM model (including assessment, pharmacotherapy, brief counseling, harm reduction, triage to appropriate level of care, navigation to community services and primary care, and related care) were compared with individuals who did not receive care through the RAAM model.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was a composite measure of ED visits for any reason, hospitalization for any reason, and all-cause mortality (all measured up to 30 days after index date). Outcomes up to 90 days after index date, as well as outcomes looking at opioid-related ED visits and hospitalizations, were also assessed.<\/jats:p><\/jats:sec>Results<\/jats:title>In analyses of the sample of 876 patients formed using propensity score matching, 440 in the RAAM group (mean [SD] age, 36.5 [12.6] years; 276 [62.7%] male) and 436 in the control group (mean [SD] age, 36.8 [13.8] years; 258 [59.2%] male), the pooled odds ratio (OR) for the primary, 30-day composite outcome of all-cause ED visit, hospitalization, or mortality favored the RAAM model (OR, 0.68; 95% CI, 0.50-0.92). Analysis of the same outcome for opioid-related reasons only also favored the RAAM intervention (OR, 0.47; 95% CI, 0.29-0.76). Findings for the individual events of hospitalization, ED visit, and mortality at both 30-day and 90-day follow-up also favored the RAAM model, with comparisons reaching statistical significance in most cases.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort study of individuals with POU, RAAM clinics were associated with reductions in ED visits, hospitalizations, and mortality. These findings provide valuable evidence toward a broadened adoption of the RAAM model in other regions of North America and beyond.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.44528","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T16:34:48Z","timestamp":1700670888000},"page":"e2344528","source":"Crossref","is-referenced-by-count":13,"title":["Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use"],"prefix":"10.1001","volume":"6","author":[{"given":"Kim","family":"Corace","sequence":"first","affiliation":[{"name":"Substance Use and Concurrent Disorders Program, Royal Ottawa Mental Health Centre, Ottawa, Ontario, Canada"},{"name":"Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"University of Ottawa Institute of Mental Health Research at The Royal, Ottawa, Ontario, Canada"},{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kednapa","family":"Thavorn","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Suschinsky","sequence":"additional","affiliation":[{"name":"Substance Use and Concurrent Disorders Program, Royal Ottawa Mental Health Centre, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Willows","sequence":"additional","affiliation":[{"name":"Substance Use and Concurrent Disorders Program, Royal Ottawa Mental Health Centre, Ottawa, Ontario, Canada"},{"name":"Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"University of Ottawa Institute of Mental Health Research at The Royal, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Leece","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Substance Use Service, Women\u2019s College Hospital, Toronto, Ontario, Canada"},{"name":"Public Health Ontario, Toronto, Ontario, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meldon","family":"Kahan","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Substance Use Service, Women\u2019s College Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Nijmeh","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Lakeridge Health, Oshawa, Ontario, Canada"},{"name":"Department of Family Medicine, Queens University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Aubin","sequence":"additional","affiliation":[{"name":"Health Sciences North, Sudbury, Ontario, Canada"},{"name":"School of Northern and Rural Health, Laurentian University, Sudbury, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roach","sequence":"additional","affiliation":[{"name":"Health Sciences North, Sudbury, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gord","family":"Garner","sequence":"additional","affiliation":[{"name":"Community Addictions Peer Support Association, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refik","family":"Saskin","sequence":"additional","affiliation":[{"name":"Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Rice","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada"},{"name":"St Joseph\u2019s Healthcare Hamilton, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Taha","sequence":"additional","affiliation":[{"name":"Canadian Centre on Substance Use and Addiction, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Garber","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"zoi231300r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: a yearly assessment from 2010 to 2019\u201d.","volume":"110","author":"Krawczyk","year":"2022","journal-title":"Int J Drug Policy"},{"issue":"3","key":"zoi231300r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019.","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi231300r9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/02791072.1993.10472244","article-title":"Strategies for increasing retention in methadone programs.","volume":"25","author":"Condelli","year":"1993","journal-title":"J Psychoactive Drugs"},{"issue":"2","key":"zoi231300r10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0376-8716(96)01273-2","article-title":"Patient retention in mobile and fixed-site methadone maintenance treatment.","volume":"42","author":"Greenfield","year":"1996","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi231300r11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1017\/cem.2019.453","article-title":"Identification of emergency department patients for referral to rapid-access addiction services.","volume":"22","author":"Hann","year":"2020","journal-title":"CJEM"},{"issue":"6","key":"zoi231300r19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention.","volume":"32","author":"D\u2019Onofrio","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"16","key":"zoi231300r20","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial.","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"zoi231300r21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/15332985.2021.1927936","article-title":"A brief report on rapid access to medication assisted treatment.","volume":"19","author":"Baslock","year":"2021","journal-title":"Soc Work Ment Health"},{"issue":"2","key":"zoi231300r22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/ADM.0000000000000559","article-title":"Alcohol medical intervention clinic: a rapid access addiction medicine model reduces emergency department visits.","volume":"14","author":"Corace","year":"2020","journal-title":"J Addict Med"},{"issue":"1","key":"zoi231300r23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13011-019-0250-1","article-title":"A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use.","volume":"15","author":"Wiercigroch","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"10","key":"zoi231300r25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","article-title":"The reporting of studies conducted using observational routinely-collected health data (RECORD) statement.","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"zoi231300r26","doi-asserted-by":"publisher","first-page":"m4856","DOI":"10.1136\/bmj.m4856","article-title":"STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies.","volume":"372","author":"Wang","year":"2021","journal-title":"BMJ"},{"issue":"10","key":"zoi231300r27","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/aje\/kwi307","article-title":"Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods.","volume":"162","author":"Zhou","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"3","key":"zoi231300r30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"1","key":"zoi231300r31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13722-021-00240-y","article-title":"Facilitating rapid access to addiction treatment: a randomized controlled trial.","volume":"16","author":"Srivastava","year":"2021","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"zoi231300r32","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.annemergmed.2019.08.026","article-title":"Implementation of a substance use disorder bridge clinic.","volume":"74","author":"Koser","year":"2019","journal-title":"Ann Emerg Med"},{"key":"zoi231300r33","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"zoi231300r34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"issue":"3","key":"zoi231300r35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/add.v113.3","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"issue":"4","key":"zoi231300r36","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1017\/cem.2019.24","article-title":"Buprenorphine\/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers.","volume":"21","author":"Hu","year":"2019","journal-title":"CJEM"},{"key":"zoi231300r1","unstructured":"United Nations. World Drug Report 2023. 2023. Accessed October 19, 2023. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html"},{"key":"zoi231300r2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2021: Trends and Developments. 2021. Accessed October 19, 2023. https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13838\/TDAT21001ENN.pdf"},{"key":"zoi231300r3","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario). Interactive Opioid Tool: opioid-related morbidity and mortality in Ontario. 2023. Accessed October 19, 2023. https:\/\/www.publichealthontario.ca\/en\/Data-and-Analysis\/Substance-Use\/Interactive-Opioid-Tool"},{"key":"zoi231300r4","unstructured":"Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid- and Stimulant-Related Harms in Canada. 2023. Accessed October 19, 2023. https:\/\/health-infobase.canada.ca\/src\/doc\/SRHD\/Update_Hospitalizations_2023-09.pdf"},{"key":"zoi231300r5","unstructured":"McQuaid? R, Malik? A, Moussani? K, . Life in Recovery from Addiction in Canada. 2017. Accessed October 19, 2023. https:\/\/www.ccsa.ca\/sites\/default\/files\/2019-04\/CCSA-Life-in-Recovery-from-Addiction-Report-2017-en.pdf"},{"key":"zoi231300r6","unstructured":"Pirie? T, Wallingford? S, Di Gioacchino? L, . National Treatment Indicators Report: 2013\u20132014. 2016. Accessed October 19, 2023. https:\/\/www.ccsa.ca\/sites\/default\/files\/2019-04\/CCSA-National-Treatment-Indicators-Report-2016-en.pdf"},{"key":"zoi231300r12","unstructured":"META:PHI. A guide to rapid access addiction medicine clinics. 2017. Accessed October 19, 2023. https:\/\/www.metaphi.ca\/wp-content\/uploads\/Model_GuideToRAAMClinics.pdf\"https:\/\/www.metaphi.ca\/assets\/documents\/the%20model\/GuideToRAAMClinics.pdf\""},{"key":"zoi231300r13","unstructured":"META:PHI. META:PHI RAAM clinic quality targets. 2018. Accessed October 19, 2023. https:\/\/www.metaphi.ca\/wp-content\/uploads\/QualityTargets.pdf"},{"key":"zoi231300r14","unstructured":"Manitoba. Manitoba to fund rapid access to addiction medicine clinics. May 8, 2018. Accessed October 19, 2023. https:\/\/news.gov.mb.ca\/news\/index.html?item=43894"},{"key":"zoi231300r15","unstructured":"Integrated Substance Abuse Programs UCLA. Integrated Substance Abuse Programs. 2017. Accessed October 19, 2023. https:\/\/www.uclaisap.org\/html2\/overview.html"},{"key":"zoi231300r16","unstructured":"Goodnough? A. This E.R. Treats Opioid Addiction on Demand; That\u2019s Very Rare. New York Times. 2018. Accessed October 19, 2023. https:\/\/www.nytimes.com\/2018\/08\/18\/health\/opioid-addiction-treatment.html?hp&action=click&pgtype=Homepage&clickSource=story-heading&module=first-column-region®ion=top-news&WT.nav=top-news"},{"key":"zoi231300r17","unstructured":"Bernstein? E, Walley? A, Beltrame? L. Faster Paths to Treatment: Opioid Urgent Care Center. Paper presented at: Boston Public Health Commission; 2018; Boston, Massachusetts. https:\/\/www.boston.gov\/sites\/default\/files\/file\/2021\/03\/Faster%20Paths%20Presentation%209%2021%2016%5B2%5D.pdf"},{"key":"zoi231300r18","unstructured":"Sadwith? T. Emergency Department Treatment and Follow-up Strategies for Opioid Use Disorder\u2014Reducing Substance Use Disorders: National Webinar Series. 2017. Accessed October 19, 2023. https:\/\/www.medicaid.gov\/state-resource-center\/innovation-accelerator-program\/iap-downloads\/program-areas\/fued-webinar.pdf"},{"key":"zoi231300r24","unstructured":"Rice DB, Hutton B, Thavorn K. RAAM. Center for Open Science. May 2020. Accessed November 3, 2023. https:\/\/osf.io\/rvewz\/?view_only=4470ef5790db42339fc0f1bee737cde8"},{"key":"zoi231300r28","unstructured":"Harvey? R, Drzayich? D, Mosley D. Random assignment of proxy event dates to unexposed individuals in observational studies: an automated technique using SAS\u00ae. 2012. Accessed October 19, 2023. https:\/\/www.mwsug.org\/proceedings\/2012\/PH\/MWSUG-2012-PH02.pdf"},{"key":"zoi231300r29","unstructured":"Gately? R, Turnbull? B. Incidence-density sampling: alternative programming approaches to achieve the same end. 2009. Accessed October 19, 2023. https:\/\/www.lexjansen.com\/nesug\/nesug09\/ph\/PH12.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2812263\/corace_2023_oi_231300_1700083515.93125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T16:34:57Z","timestamp":1700670897000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2812263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.44528","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]}}}